PACLITAXEL MYLAN
6MG/ML INF CNC SOL 1X16,7ML
SÚKL code | 0136247 |
---|---|
Name of the product | PACLITAXEL MYLAN |
_MA_MEDICATION_DETAIL_INFO_MED_NAME i | PACLITAXEL MYLAN |
Supplement | 6MG/ML INF CNC SOL 1X16,7ML |
Strenght | 6MG/ML |
Pharmaceutical form | Concentrate for solution for infusion |
Package | 1X16,7ML |
Route | Intravenous use |
Wrap type | Vial |
Legal status | na lékařský předpis |
Active substance | PACLITAXEL (PACLITAXELUM) |
ATC group | L01CD01 |
ATC group name | PAKLITAXEL |
Marketing authorisation information
Registration Number | 44/ 172/07-C |
---|---|
Type of MA | A mutual recognition procedure (MRP, DCP), where CZ is Concerned member state |
MA status | B - medicinal product after change, may be placed on the market for the period of 6 months (Placed on the market till) and used until expiration, not later than till the end of validity of the marketing authorisation (Valid till) |
Placed on the market till | 30. 06. 2022 |
MA Holder | Mylan S.A.S., Saint-Priest |
MA Holder country | FRANCIE |
Actual MA holder | VIATRIS LIMITED, Dublin |
Actual MA holder country | IRSKO |